Efficacy of Gemigliptin Add-on to Dapagliflozin and Metformin in Type 2 Diabetes Patients: A Randomized, Double-Blind, Placebo-Controlled Study (SOLUTION) - Lee, Byung Wan; Min, KyungWan; Hong, Eun-Gyoung; Ku, Bon Jeong; Kang, Jun Goo; Chon, Suk; Lee, Won-Young; Park, Mi Kyoung; Kim, Jae Hyeon; Kim, Sang Yong; Song, Keeho; Yoo, Soon Jib (Endocrinology and metabolism (Seoul), 2023)
Keywords: Blood Glucose; dapagliflozin; diabetes mellitus, type 2; Diabetes Mellitus, Type 2 - drug therapy; Diabetes Mellitus, Type 2 - epidemiology; dipeptidyl-peptidase iv inhibitors; gemigliptin; Glycated Hemoglobin; Humans; Hypoglycemic Agents; metformin; Metformin - therapeutic use; Original; sodium-glucose transporter 2 inhibitors; 내과학; Sodium-glucose transporter 2 inhibitors; Metformin; Diabetes mellitus, type 2; Gemigliptin; Dapagliflozin; Dipeptidyl-peptidase IV inhibitors